In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae.
about
Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data.High genetic diversity of ciprofloxacin-nonsusceptible isolates of Streptococcus pneumoniae in Poland.Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003.Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniaeSusceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countriesIncidence, epidemiology, and characteristics of quinolone-nonsusceptible Streptococcus pneumoniae in CroatiaDNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis.Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia.Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci.Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groupsIn vitro antibacterial activity of NB-003 against Propionibacterium acnes.Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniaeIn vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin.Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant Enterococci.Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents.In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococciAntistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin.Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agentsCapability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologiesAntipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agentsAntipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin.In vitro resistance selection studies of RLP068/Cl, a new Zn(II) phthalocyanine suitable for antimicrobial photodynamic therapy.Levofloxacin failure in a patient with pneumococcal pneumonia.Molecular analysis of type II topoisomerases of Aeromonas hydrophila isolated from fish and levofloxacin-induced resistant isolates in vitro.
P2860
Q33187513-179709BD-4EE0-4867-B932-2F4E35CC4900Q33770218-659CE5FA-A65D-4A67-AEE0-481F4DC99FEEQ33883600-444034CF-D08D-43D0-BED2-9F8F586336F7Q33983643-E0B966B1-1C1B-44C7-921A-9BBC4855873FQ34105521-3216444D-740D-411A-82C3-CAB556445E60Q34110467-4BA35F76-7BEE-4F56-8DD6-05AD044BBB9BQ34111196-7B73F1A2-0FF7-4719-A4E9-9231E9B5C31FQ34112023-C854B225-EAD7-4383-B449-98F4F30B9E9BQ35599090-17FE1E0C-F9F4-4C51-AF69-D182B52BAB6BQ35635797-8A0F6E28-5F94-411F-A0C7-66825F3C3692Q35758905-0621D688-BEAD-4E3D-AC5E-9E7FB908622BQ38283280-641F1F06-238B-4C98-A29D-1B802611243EQ39478343-213B70C4-D91B-4594-8B84-20885D3A3047Q39652872-996CF31F-B081-4F32-BFD8-A182A798C449Q40290408-A259E202-D9AD-41E1-BF40-BE557272413BQ40313144-5C406955-28B3-48B2-AD03-725A5791B1E3Q40345358-1EC7B502-7732-4A9E-A590-A6FFB1727541Q41825665-F3CF8BFF-FA67-403D-BAC6-61AD59DE2011Q41847350-B64A92C6-723D-4C6B-B4C0-E0BD4192CA7AQ41869954-B9683438-F2C7-4B5A-BAC6-BA88F57EAF22Q42112086-3AD3384A-3515-4240-83C7-FE475BED5344Q42112427-F64571C6-4F8C-4775-B911-A40FB93EA0F3Q42112713-0ABE2330-9BC4-4724-A81E-33163696B517Q42929756-E00D1146-B869-49F6-8B28-35FCD4DB170FQ43642324-5985E6F6-0E61-4405-B38F-752F369D19FFQ53811839-DA6260BA-0ACA-4AF0-A1C5-6EA4E3F7D73A
P2860
In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
In vitro selection of resistan ...... n in Streptococcus pneumoniae.
@en
In vitro selection of resistan ...... n in Streptococcus pneumoniae.
@nl
type
label
In vitro selection of resistan ...... n in Streptococcus pneumoniae.
@en
In vitro selection of resistan ...... n in Streptococcus pneumoniae.
@nl
prefLabel
In vitro selection of resistan ...... n in Streptococcus pneumoniae.
@en
In vitro selection of resistan ...... n in Streptococcus pneumoniae.
@nl
P2093
P2860
P1476
In vitro selection of resistan ...... n in Streptococcus pneumoniae.
@en
P2093
B E Dewasse
G A Pankuch
M R Jacobs
P C Appelbaum
T A Davies
P2860
P304
P356
10.1128/AAC.44.10.2740-2746.2000
P407
P577
2000-10-01T00:00:00Z